NASDAQ$BIOX
Bioceres Crop Solutions Corp · Q4 2024 earnings
Q4 2024 earnings · · Investor relations
Briefing
BIOX Q4 2024 — BRL 464.8M revenue
These forward-looking statements include information about possible or assumed future results of our business, financial condition, results of operations, liquidity, anticipated growth strategies, ant. Bioceres Crop Solutions Corp reported Q4 2024 results. Net income of BRL 6.2M. Headline numbers extracted from the Form 20-F press release; narrative is light because this row was processed without an LLM call.
- Revenue: BRL 464.8M.
- Net income: BRL 6.2M.
- Operating income: BRL 44.8.
- Gross profit: BRL 186.6.
Headline financials
Revenue & EPS history
Bioceres · Revenue · Quarterly
$124M
Revenue by segment
Bioceres · $39.4M total across 3 segments · Q3 2026
- Crop protection$24.6M-42.3%62.4%
- Crop nutrition$11.6M+49.2%29.4%
- Seed and integrated products$3.2M-68.5%8.1%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q4 2024
-0.9%
Avg return
Earnings day
-0.0%
Avg return
5 days after
-3.9%
Avg return
30 days after
41%
12 / 29 earnings
Positive
+12.6%
Q3 2023
Best reaction
-14.4%
Q4 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2026 | -5.6% | -20.1% | -20.7% | |
| Q2 2026 | -9.2% | -12.8% | -16.0% | |
| Q3 2025 | -5.2% | -0.4% | -2.4% | |
| Q4 2024 | -14.4% | -15.2% | -26.2% | |
| Q3 2024 | -7.0% | -10.8% | -16.2% | |
| Q2 2024 | +4.0% | +3.1% | +1.5% | |
| Q1 2024 | +6.7% | +13.6% | +28.0% | |
| Q4 2023 | -2.3% | -0.4% | -4.1% | |
| Q3 2023 | +12.6% | +20.3% | +22.5% | |
| Q2 2023 | -8.4% | -2.4% | -6.8% | |
| Q1 2023 | +5.5% | +1.9% | -12.7% | |
| Q4 2022 | -2.9% | -2.9% | -10.3% | |
| Q3 2022 | +5.4% | +12.8% | +9.7% | |
| Q2 2022 | +1.8% | +1.4% | +19.1% | |
| Q1 2022 | +8.2% | +15.9% | +9.0% | |
| Q4 2021 | -6.5% | -8.2% | -2.2% | |
| Q3 2021 | +3.0% | +5.6% | -5.3% | |
| Q2 2021 | -1.9% | -1.7% | -7.5% | |
| Q1 2021 | -0.2% | -0.7% | -7.2% | |
| Q4 2020 | +4.8% | +7.0% | +17.9% | |
| Q3 2020 | -6.6% | -1.9% | -4.0% | |
| Q2 2020 | +4.7% | +13.5% | -12.5% | |
| Q1 2020 | -5.5% | -0.7% | -7.7% | |
| Q4 2019 | +0.0% | -7.4% | -6.6% | |
| Q3 2019 | -8.7% | -11.1% | -7.2% | |
| Q2 2019 | +0.2% | +0.2% | -47.4% | |
| Q1 2019 | +0.0% | +0.0% | +2.6% | |
| Q4 2018 | +0.2% | +0.0% | +0.2% | |
| Q3 2018 | +0.0% | +0.7% | +0.5% | |
| Q2 2017 | — | — | — | |
| Q1 2017 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro